116
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Mesoporous particle-based microcontainers for intranasal delivery of imidazopyridine drugs

, ORCID Icon, , , , , , & show all
Pages 657-666 | Received 14 Sep 2018, Accepted 14 Jan 2019, Published online: 05 Feb 2019

References

  • Antipov, A.A., et al., 2003. Carbonate microparticles for hollow polyelectrolyte capsules fabrication. Colloids and surfaces A: physicochemical and engineering aspects, 224 (1–3), 175–183.
  • Armarego, W. L. F. and Perrin, D. D., 1997. Purification of laboratory chemicals. 4th edn. Oxford, Boston: Butterworth-Heinemann.
  • Balter, M.B. and Levine, J., 1971. Character and extent of psychotherapeutic drug usage in the United States. 5th World congress of psychiatry, Paper presented at the 5th World congress of psychiatry, November 30, 1971, Mexico City. pp. 28–30.
  • Borodina, T., et al., 2018. A novel formulation of zolpidem for direct nose-to-brain delivery: synthesis, encapsulation and intranasal administration to mice. Journal of pharmacy and pharmacology, 70 (9), 1164–1173.
  • Borodina, T.N., et al., 2016. Calcium carbonate-based mucoadhesive microcontainers for intranasal delivery of drugs bypassing the blood-brain barrier. Bionanoscience, 6 (3), 261–268.
  • Bukreeva, T.V., et al., 2011. Calcium carbonate and titanium dioxide particles as a basis for container fabrication for brain delivery of compounds. Doklady physical chemistry, 440 (1), 165–167.
  • Chernyak, N. and Gevorgyan, V., 2010. General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: one-pot synthesis of alpidem and zolpidem. Angewandte chemie international edition i, 49: 2743–2746.
  • Donatan, S., et al., 2016. Loading capacity versus enzyme activity in anisotropic and spherical calcium carbonate microparticles. ACS applied materials & interfaces, 8 (22), 14284–14292.
  • Fau, D., et al., 1994. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. The journal of pharmacology and experimental therapeutics, 269 (3), 954–962.
  • Fraser, G.L., et al., 2013. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Critical care medicine, 41, 30–38.
  • Guetzoyan, L., et al., 2013. Flow chemistry synthesis of zolpidem, alpidem and other GABAA agonists and their biological evaluation through the use of in-line frontal affinity chromatography. Chemical science, 4 (2), 764–769.
  • Gunja, N., 2013. In the Zzz zone: the effects of Z-drugs on human performance and driving. Journal of medical toxicology: official journal of the American College of Medical Toxicology, 9 (2), 163–171.
  • Inagaki, T., et al., 2010. Adverse reactions to zolpidem. Primary care companion to the journal of clinical psychiatry, 12 (6), pii: PCC.09r00849.
  • Lai, Y.-K., et al., 2016. TiO2 nanotube platforms for smart drug delivery: a review. International journal of nanomedicine, 11, 4819–4834.
  • Lei, X., et al., 2016. Method for preparing compound zolpidem. Patent CN103360387 A.
  • Licata, S.C. and Rowlett, J.K., 2008. Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond. Pharmacology biochemistry and behavior, 9, 74–89.
  • Mets, M.A.J., et al., 2010. Effect of hypnotic drugs on body balance and standing steadiness. Sleep medicine reviews, 14 (4), 259–267.
  • Nair, D.K., Mobin, S.M., and Namboothiri, I.N.N., 2012. Synthesis of imidazopyridines from the Morita-Baylis-Hillman acetates of nitroalkenes and convenient access to alpidem and zolpidem. Organic letters, 14 (17), 4580–4583.
  • Pagano, J.S., McCutchan, J.H., and Vaheri, A., 1967. Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. Journal of virology, 1, 891–897.
  • Peng, C., Zhao, Q., and Gao, C., 2010. Sustained delivery of doxorubicin by porous CaCO3 and chitosan/alginate multilayers-coated CaCO3 microparticles. Colloids and surfaces A: physicochemical and engineering aspects, 353 (2–3), 132–139.
  • Petrov, A.I., Volodkin, D.V., and Sukhorukov, G.B., 2008. Protein-calcium carbonate coprecipitation: a tool for protein encapsulation. Biotechnology progress, 21 (3), 918–925.
  • Porecha, S., et al., 2009. Microemulsion based intranasal delivery system for treatment of insomnia. Drug delivery, 16 (3), 128–134.
  • Procyshyn, R. M., Bezchlibnyk-Butler, K. Z., and Jeffries, J. J., 2017. Clinical handbook of psychotropic drugs. 22nd ed. Boston, USA: Hogrefe Publishing,p. 439.
  • Qiu, N., et al., 2012. Calcium carbonate microspheres as carriers for the anticancer drug camptothecin. Materials science and engineering C, 32 (8), 2634–2640.
  • Radha, A.V. and Navrotsky, A., 2014. Manganese carbonate formation from amorphous and nanocrystalline precursors: thermodynamics and geochemical relevance. American mineralogist, 99 (5–6), 1063–1070.
  • Rassokhina, I.V., et al., 2015. Copper(II)-mediated aerobic synthesis of imidazo[1,2-a] pyridines via cascade aminomethylation/cycloisomerization of alkynes. The journal of organic chemistry, 80 (21), 11212–11218.
  • Ries, R. K., Miller, S. C., and Fiellin, D. A., 2014. Principles of addiction medicine. Philadelphia, USA: Lippincott Williams & Wilkins.
  • Shieh, D.-L., et al., 2007. A novel approach to mesoporous anatase TiO2: oxidation of TiC by nitric acid. Microporous mesoporous mater, 98 (1–3), 339–343.
  • Siriwardena, A.N., et al., 2008. Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. British journal of general practice, 58 (551), 417–422.
  • Soane, R., et al., 1999. Evaluation of the clearance characteristics of bioadhesive systems in humans. International journal of pharmaceutics, 178 (1), 55–65.
  • Sukhorukov, G.B., et al., 1998. Stepwise polyelectrolyte assembly on particle surfaces: a novel approach to colloid design. Polymers for advanced technologies, 9 (10–11), 759–767.
  • Svenskaya, Y., et al., 2013. Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer. Biophysical chemistry, 182, 11–15.
  • Svenskaya, Y.I., et al., 2016. Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles. Colloids surfaces B biointerfaces, 146, 171–179.
  • Tasciotti, E., et al., 2008. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nature nanotechnology, 3 (3), 151.
  • Tripodo, G., et al., 2015. Hyaluronic acid and its derivatives in drug delivery and imaging: recent advances and challenges. European journal of pharmaceutics and biopharmaceutics, 97 (Pt B), 400–416.
  • Trushina, D.B., et al., 2014. CaCO3 vaterite microparticles for biomedical and personal care applications. Materials science and engineering C: materials for biological applications, 45, 644–658.
  • Trushina, D.B., et al., 2015. Size control and structure features of spherical calcium carbonate particles. Crystallography reports, 60 (4), 570–577.
  • Virani, A.S., et al., 2012. Book review: clinical handbook of psychotropic drugs, 19th revised edition. Mental health clinician, 1 (11), 288–289.
  • Volodkin, D.V., et al., 2004. Matrix polyelectrolyte microcapsules: new system for macromolecule encapsulation. Langmuir, 20 (8), 3398–3406.
  • Wagner, J. and Wagner, M.L., 2000. Non-benzodiazepines for the treatment of insomnia. Sleep medicine reviews, 4 (6), 551–581.
  • Wang, Y., et al., 2015. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine: nanotechnology, biology and medicine, 11 (2), 313–327.
  • Zhu, H., et al., 2005. Synthesis of size-controlled monodisperse manganese carbonate microparticles as templates for uniform polyelectrolyte microcapsule formation. Chemistry of materials, 17 (9), 2323–2328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.